The 13th Annual Georgetown Meeting on Gastrointestinal Endoscopy & Pancreatobiliary Surgery

The 13th Annual Georgetown Meeting on Gastrointestinal Endoscopy & Pancreatobiliary Surgery Banner


Date & Location
Saturday, October 20, 2018, 7:00 AM - 4:00 PM, The Ritz-Carlton, Washington, DC

Target Audience
Gastroenterology, Oncology, Radiation Oncology, Radiology, Surgery

Overview
Pancreatic and biliary diseases have poor prognosis and their diagnosis and management remains a challenge to clinicians despite new developments in diagnostic techniques and therapeutic options. 

This one-day symposium highlights the role of multidisciplinary approach including the new developments in endoscopic and radiologic imaging and surgical approaches to pancreatic and biliary diseases. We will review the newest advances in oncology to pancreatic cancer. The course will address new developments in the treatment of neoplastic and benign esophageal disorders, both endoscopic and surgical approaches. The assessment, diagnoses, and management of neuroendocrine tumors will be reviewed as well.  



Objectives

After completing this activity, the participant will be able to;
  1. Implement the best practice for imaging and surgical approaches to diagnosing and treating pancreatic cancer
  2. Recognize the newest advances in personalized medicine for oncologic treatment of pancreatic cancer
  3. Utilize the appropriate decision making process to determine which patients with Barrett's esophagus to treat with endoscopic ablation
  4. Identify the new diagnostic modalities used to treat neuroendocrine tumors
  5. Identify the new endoscopic techniques to treat endocrine tumors
  6. Utilize endoscopic therapy for the treatment of benign esophageal disorders
  7. Define the technique for obtaining FNAs in pancreatic lesions
  8. Define how to treat Neuroendocrine tumors with EUS guided approach to ablate tumors
  9. Implement the best practice for imaging and surgical approaches to diagnosing and treating pancreatic cancer
  10. Recognize the newest advances in personalized medicine for oncologic treatment of pancreatic cancer
  11. Utilize the appropriate decision making process to determine which patients with Barrett's esophagus to treat with endoscopic ablation
  12. Identify the new diagnostic modalities used to treat neuroendocrine tumors
  13. Identify the new endoscopic techniques to treat endocrine tumors
  14. Utilize endoscopic therapy for the treatment of benign esophageal disorders

Registration

Registration Fees

  • Physician $250
  • Resident/Fellow $50
  • Physician Assistant: $100Nurse Practitioner $100Nurse $100Allied Health Professional $100


Accreditation

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.



Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 5.75 Interprofessional Continuing Education (IPCE) credits for learning and change.